Latest News

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Fluence Energy (NasdaqGS:FLNC) experienced a 14% price increase over the past week, with business expansions playing a crucial role. The company started production at a new facility in Arizona, focusing on U.S.-made enclosures and battery management system hardware, aligning with industry goals of bolstering domestic manufacturing and energy security. This event occurred against a backdrop of market volatility due to Middle East tensions and anticipation over the Federal Reserve's interest...

With a median price-to-earnings (or "P/E") ratio of close to 18x in the United States, you could be forgiven for...

Key Insights Reliance's estimated fair value is US$279 based on 2 Stage Free Cash Flow to Equity With US$310 share...

Catalyst Pharmaceuticals (NasdaqCM:CPRX) recently appointed Dr. William T. Andrews as Chief Medical Officer, a move that underscores the company's focus on advancing its leadership in rare disease therapeutics. Over the last quarter, Catalyst Pharmaceuticals' stock experienced a price move of 2.74%. This moderate gain aligns with broader market trends that saw a 9.8% increase over the year, alongside earnings growth anticipation. Moreover, the company's strong earnings report, with Q1 2025...

Fortinet (NasdaqGS:FTNT) recently announced updates to its Lacework FortiCNAPP, enhancing the security of cloud-native applications, introducing real-time alerting and expanding its services on AWS Marketplace. Throughout the last quarter, the company’s share price increased by 5%, reflecting its advancements in cloud security solutions and market expansion. This occurred amidst global market volatility due to geopolitical tensions in the Middle East and anticipation around Federal Reserve...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...

CME Group (NasdaqGS:CME) recently announced plans to launch E-Mini S&P BMV IPC Index futures, expanding access to the Mexican equity market. Over the last quarter, the company's share price increased by 2%, aligning with broader market trends like the Fed's stable interest rates and geopolitical tensions affecting global markets. This modest growth comes amid earnings growth, a declared $1.25 dividend, and the strategic introduction of new financial products, including cryptocurrency indices...

Cognizant Technology Solutions (NasdaqGS:CTSH) recently partnered with Google Cloud to release the Cognizant® Autonomous Customer Engagement solution, an AI-driven platform aimed at transforming customer interactions. Although the company's stock price saw minimal change over the last quarter, several key events could have influenced its stability. These include Cognizant's open-sourcing of its Neuro AI Multi-Agent Accelerator and expanded collaboration with Pegasystems, potentially...

Nucor (NYSE:NUE) recently provided new earnings guidance for the second quarter ending July 5, 2025, expecting earnings between $2.55 and $2.65 per diluted share. Although this projection is a decline from the $2.68 per diluted share reported in the same quarter the previous year, it is significantly higher than the $0.67 reported in Q1 2025. This guidance, along with the announcement of its regular quarterly cash dividend, might have supported a 5% price movement over the last month. While...

Texas Instruments (NasdaqGS:TXN) recently announced a substantial $60 billion investment to build seven semiconductor fabs in the U.S., aiming to strengthen domestic manufacturing and collaborate with companies like Ford, Medtronic, and NVIDIA. Over the last quarter, the company's stock price increased by 9%. This aligns closely with broader market trends, as both Texas Instruments and market indices have posted similar gains. This expansion and strategic collaborations could have added...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Celestica (TSX:CLS), following its shareholders' approval of the new By-Law 2 (Advance Notice), experienced a 37% increase over the last quarter. This rise could be supported by strong market conditions characterized by the Dow Jones and S&P 500 maintaining a positive stance amidst interest rate decisions and Middle East tensions. Additionally, Celestica's Q1 earnings report showed increased sales and an upward revision in revenue guidance, which may have contributed positively to the stock's...

Bristol-Myers Squibb (NYSE:BMY) recently announced dividend declarations for common and preferred stock, potentially adding some weight to the company's stock performance over the past month. The stock saw a modest gain of 1%, which aligns closely with broader market movements amid geopolitical and economic factors such as the Middle Eastern conflict and anticipation around the Federal Reserve's decision on interest rates. Additionally, updates regarding clinical trial results for product...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

The recent price decline of 11% in NeoGenomics, Inc.'s ( NASDAQ:NEO ) stock may have disappointed insiders who bought...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

As global markets navigate the uncertainties stemming from geopolitical tensions and anticipate the Federal Reserve's upcoming interest rate decision, investors are closely monitoring the impact on small-cap stocks within indices like the S&P 600. Amid this backdrop of volatility and fluctuating oil prices, identifying promising investment opportunities in less-explored areas of the U.S. market can be a strategic move for those looking to diversify their portfolios.

Looking at Bank First Corporation's ( NASDAQ:BFC ) insider transactions over the last year, we can see that insiders...

Amicus Therapeutics, Inc. ( NASDAQ:FOLD ) is possibly approaching a major achievement in its business, so we would like...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Copart, Inc. ( NASDAQ:CPRT ) shareholders might be concerned after seeing the share price drop 25% in the last month...

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...